Cleared Traditional

K191894 - Upper Arm Blood Pressure Monitor

K191894 is an FDA 510(k) clearance for Upper Arm Blood Pressure Monitor, manufactured by Shenzhen Zhengkang Technology Co., Ltd.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 221-day FDA review.

K191894 · Shenzhen Zhengkang Technology Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2020
Decision
221d
Days
Class 2
Risk

K191894 is an FDA 510(k) clearance for the Upper Arm Blood Pressure Monitor. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Shenzhen Zhengkang Technology Co., Ltd. (Shenzhen City, CN). The FDA issued a Cleared decision on February 21, 2020 after a review of 221 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Shenzhen Zhengkang Technology Co., Ltd. devices

FDA 510(k) Submission Details - K191894

510(k) Number K191894 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 15, 2019
Decision Date February 21, 2020
Days to Decision 221 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
96d slower than avg
Panel avg: 125d · This submission: 221d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Feiying Drug & Medical Consulting Technical Service Group
Becky Chen

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 565
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K191894.
Medtronic Commander Flex
K191745 · Medtronic Care Management Services · May 2020
BP-BT Kiosk
K200287 · Ld Technology, LLC · May 2020
Globalcare Blood Pressure Monitor
K192609 · Globalcare Medical Technology Co., Ltd. · Apr 2020
Seca Medical Vital Signs Analyzer 535, Seca mVSA 535, Seca mVSA, Seca 535
K192092 · Seca GmbH & Co. KG · Jan 2020
Arm Blood Pressure Monitor
K192023 · Truly Instrument Limited · Dec 2019
Upper Arm Blood Pressure Monitor
K191673 · Famidoc Technology Company Limited · Nov 2019